Distinct Roles of IL ‐4, IL ‐13, and IL ‐22 in Human Skin Barrier Dysfunction and Atopic Dermatitis

Documenti analoghi

• Rapid Human Skin Barrier Disruption by Sodium Dodecyl Sulfate and Associated Molecular Mechanisms
  di: Manru Li, et al.
  Pubblicazione: (2026)
• Benralizumab Depletes IL‐5Rα‐Bearing Cells in Skin Lesions of Patients With Atopic Dermatitis
  di: Christiane E. Whetstone, et al.
  Pubblicazione: (2025)
• Sphingosine 1‐Phosphate Receptor 1 and 5 Reciprocally Regulate IL ‐13 and IL ‐9 Production in Atopic Dermatitis
  di: Kazuhiko Yamamura, et al.
  Pubblicazione: (2026)
• An Anti‐IL‐13 Vaccine Reduces Atopic Dermatitis in Humanized Mice and Induces Neutralizing Antibodies in Nonhuman Primates
  di: Aurélie Mougel, et al.
  Pubblicazione: (2025)
• Semaphorin 7a Regulates the Expression of IL‐4 and IL‐33 in a Cell Model of Atopic Dermatitis and Is Associated With Disease Severity
  di: Mindy Ming‐Huey Guo, et al.
  Pubblicazione: (2025)